UBS US Equity Opportunity A (BNVAX)
8.75 0.02(0.23%) Dec 4
* As of 31-Oct-13
Quotes delayed, except where indicated otherwise. Currency in USD.
- No Headlines available for BNVAX at this time.
|Symbol||% Assets||YTD Return %|
|Morningstar Overall Rating:|
|Annual Report Expense Ratio (net):||1.20%|
Performance & Risk
|5y Avg Return:||11.46%|
|Rank in Category (ytd):||29|
|% Rank in Category (ytd):||1.82%|
|Morningstar Risk Rating:||5|
The investment seeks to maximize total return through capital appreciation and current income.
The fund invests at least 80% of its net assets (plus borrowings for investment purposes, if any) in equity securities of US companies. It primarily invests in large capitalization companies, but may invest in companies of any size. The fund may invest up to 20% of its net assets in securities of foreign companies in both developed and emerging markets. It may, but is not required to, use exchange-traded or over-the-counter derivative instruments. View More